Publication | Closed Access

Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties

InflammationSmall Molecule InhibitorsMedicinal ChemistryAnti-inflammatoryMedicineNatural SciencesGlycobiologyImmunologyAnti-inflammatory PropertiesPharmacologyProtein InteractionSmall MoleculesDrug DiscoveryGlycosylation